Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2033 ARTÍCULOS , VIENDO DEL 1561 AL 1575

Neuropathology of the Common Forms of Dementia

Mehta RI, Schneider JA.

Clin Geriatr Med. 2023 Feb;39(1):91-107. doi: 10.1016/j.cger.2022.07.005. Epub 2022 Oct 18.

The fate of interneurons, GABA(A) receptor sub-types and perineuronal nets in Alzheimer's disease

Ali AB, Islam A, Constanti A.

Brain Pathol. 2023 Jan;33(1):e13129. doi: 10.1111/bpa.13129. Epub 2022 Nov 21.

A Potential Link Between Visceral Obesity and Risk of Alzheimer's Disease

Al-Kuraishy HM, Al-Gareeb AI, Alsayegh AA, Hakami ZH, Khamjan NA, Saad HM, Batiha GE, De Waard M.

Neurochem Res. 2023 Mar;48(3):745-766. doi: 10.1007/s11064-022-03817-4. Epub 2022 Nov 21.

Benzodiazepines in Alzheimer's disease: beneficial or detrimental effects

Al-Kuraishy HM, Al-Gareeb AI, Saad HM, Batiha GE.

Inflammopharmacology. 2023 Feb;31(1):221-230. doi: 10.1007/s10787-022-01099-4. Epub 2022 Nov 23.

Role of estrogen in women's Alzheimer's disease risk as modified by APOE

Valencia-Olvera AC, Maldonado Weng J, Christensen A, LaDu MJ, Pike CJ.

J Neuroendocrinol. 2023 Feb;35(2):e13209. doi: 10.1111/jne.13209. Epub 2022 Nov 24.

Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights

Oliyaei N, Moosavi-Nasab M, Tanideh N, Iraji A.

Brain Res Bull. 2023 Feb;193:11-21. doi: 10.1016/j.brainresbull.2022.11.018. Epub 2022 Nov 23.

Nanomedicine-based immunotherapy for Alzheimer's disease

Hoque M, Samanta A, Alam SSM, Zughaibi TA, Kamal MA, Tabrez S.

Neurosci Biobehav Rev. 2023 Jan;144:104973. doi: 10.1016/j.neubiorev.2022.104973. Epub 2022 Nov 23.

Exosome-based approaches in the management of Alzheimer's disease

Kandimalla R, Saeed M, Tyagi N, Gupta RC, Aqil F.

Neurosci Biobehav Rev. 2023 Jan;144:104974. doi: 10.1016/j.neubiorev.2022.104974. Epub 2022 Nov 23.

Biomechanical forces in the aged brain: Relationship to AD

Lee GY, Kim OH, Kim ER, Lee HJ.

Life Sci. 2023 Jan 1;312:121237. doi: 10.1016/j.lfs.2022.121237. Epub 2022 Nov 24.

Physiological Roles of β-amyloid in Regulating Synaptic Function: Implications for AD Pathophysiology

Cai W, Li L, Sang S, Pan X, Zhong C.

Neurosci Bull. 2023 Aug;39(8):1289-1308. doi: 10.1007/s12264-022-00985-9. Epub 2022 Nov 28.

Promoting Endogenous Neurogenesis as a Treatment for Alzheimer's Disease

Zhang Q, Liu J, Chen L, Zhang M.

Mol Neurobiol. 2023 Mar;60(3):1353-1368. doi: 10.1007/s12035-022-03145-2. Epub 2022 Nov 29.

The metal ion hypothesis of Alzheimer's disease and the anti-neuroinflammatory effect of metal chelators

Chen LL, Fan YG, Zhao LX, Zhang Q, Wang ZY.

Bioorg Chem. 2023 Feb;131:106301. doi: 10.1016/j.bioorg.2022.106301. Epub 2022 Nov 25.

Postulating the possible cellular signalling mechanisms of antibody drug conjugates in Alzheimer's disease

Punyakoti P, Behl T, Sehgal A, Yadav S, Sachdeva M, Anwer MK, Vargas-De-La-Cruz C, Venkatachalam T, Naqvi M, Verma R, Tuli HS.

Cell Signal. 2023 Feb;102:110539. doi: 10.1016/j.cellsig.2022.110539. Epub 2022 Nov 29.

Amyloid precursor protein and mitochondria

Strope TA, Wilkins HM.

Curr Opin Neurobiol. 2023 Feb;78:102651. doi: 10.1016/j.conb.2022.102651. Epub 2022 Nov 30.

The ameliorative effects and mechanisms of abscisic acid on learning and memory

Liao P, Wu QY, Li S, Hu KB, Liu HL, Wang HY, Long ZY, Lu XM, Wang YT.

Neuropharmacology. 2023 Feb 15;224:109365. doi: 10.1016/j.neuropharm.2022.109365. Epub 2022 Nov 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias